35
LITERATŪROS SĄRAŠAS
[1] Giuseppe Nocentini, Simona Ronchetti, Stefano Bruscoli, and Carlo Riccardi. The Clinical
Pharmacology of Past, Present, and Future Glucocorticoids. In: R. Cimaz. Systemic Corticosteroids for Inflammatory Disorders in Pediatrics; 2015. p.43-48.
[2] Barbara A. Phillips. Corticosteroids in Respiratory Diseases in Children. American Journal of
Respiratory and Critical Care Medicine, Vol. 185, No. 12 (2012), p. 1328-1329.
doi: 10.1164/rccm.201107-1174CI [žiūrėta 2016-04-13]
[3] R. M. Fernandes, M.Oleszczuk, Ch. R. Woods, B. H. Rowe, Ch. J. Cates and L. Hartling. 2014. The Cochrane Library and safety of systemic corticosteroids for acute respiratory conditions in children: an overview of reviews. Evid.-Based Child Health 9: 733–747. doi:10.1002/ebch.1980 [žiūrėta 2016-08-02]
[4] N. A. Boersma, R. W.H. Meijneke, J. C. Kelder, C. K. van der Ent,W. A.F. Balemans. Sensitization predicts asthma development among wheezing toddlers in secondary healthcare. [5] Bisgaard H., Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol. 2007 Aug;42(8):723-8. DOI:10.1002/ppul.20644; [žiūrėta 2017-01-07]
[6] Fernando M. de Benedictis and Andrew Bush. 2012. Corticosteroids in Respiratory Diseases in Children. Am J Respir Crit Care Med Vol 185, Iss. 1, pp 12–23. doi:10.1164/rccm.201107-1174CI [žiūrėta 2016-08-02]
[7] A. Beigelman, B. E. Chipps, B. Bacharier. Update on the utility of corticosteroids in acute pediatric respiratory disorders. Allergy Asthma Proc. 2015 Sep-Oct; 36(5): 332–338.
doi: 10.2500/aap.2015.36.3865 [žiūrėta 2016-04-13]
[8] Andrew D. Collins and Avraham Beigelman. An update on the efficacy of oral corticosteroids in the treatment of wheezing episodes in preschool children. Therapeutic Advances in Respiratory
Disease. 2014, Vol. 8(6) 182–190 doi: 10.1177/ 1753465814552283 [žiūrėta2016-04-15]
[9] A. Beigelman, T. S. King, D. Mauger, R.S. Zeiger, R. C. Strunk,H. William Kelly, F. D. Martinez, R. F. Lemanske , K.Rivera-Spoljaric, D. J. Jackson, T. Guilbert, R. Covar, L. B. Bacharier, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol. 2013 Jun;131(6):1518-25. doi:
10.1016/j.jaci.2013.01.034. [žiūrėta 2016-04-05]
[10] Carlos Alberto Longui. Glucocorticoid therapy: minimizing side effects. J Pediatr (Rio J). 2007 Nov;83(5 Suppl):S163-77. doi:10.2223/JPED.1713. [žiūrėta 2016-08-11]
[11] Lynnette K Nieman. 2016. Pharmacologic use of glucocorticoids. Up To Date. Topic 124 Version 12.0. Prieiga per internetą:
https://www.uptodate.com/contents/pharmacologic-use-of-36 glucocorticoids?source=machineLearning&search=metabolism%20of%20adrenal%20steroids&selecte dTitle=2~150§ionRank=1&anchor=H6#H6. [žiūrėta 2016-01-08]
[12] K. G Saag, D. E Furst. 2016. Major side effects of systemic glucocorticoids. Up To Date. Topic 7988 Version 15.0. Prieiga per internetą: https://www.uptodate.com/contents/major-side-effects-of-
systemic-glucocorticoids?source=machineLearning&search=corticosteroids%20children&selectedTitle=1~150 §ionRank=1&anchor=H5; [žiūrėta 2016-08-23]
[13] Lorraine I. McKay, John A. Cidlowski. Physiologic and Pharmacologic Effects of Corticosteroids Holland-Frei Cancer Medicine. 6th edition; 2003; prieiga per internetą:
http://www.ncbi.nlm.nih.gov/books/NBK13780/; [žiūrėta 2016-08-23]
[14] Priyanka Gupta and Vijayalakshmi Bhatia. Corticosteroid Physiology and Principles of Therapy.
Indian J Pediatr 2008; 75 (10) : 1039-1044. doi:10.1007/s12098-008-0208-1 [žiūrėta 2016-06-06]
[15] Steven K. H. Adrenal cortical steroids. In: Drug facts and comparisons. 5th ed. St. Louis: Facts and Comparisons, Inc.; 1997. p.122–128
[16] Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44: 61-98. doi:10.2165/00003088-200544010-00003. [žiūrėta 2016-01-08]
[17] Daniel E Furst, Kenneth G Saag, MD. 2016. Determinants of glucocorticoid dosing. Up To Date. Topic 7976 Version 11.0. Prieiga per internetą: http://www.uptodate.com/contents/determinants-of-glucocorticoid-dosing. [žiūrėta 2016-08-02]
[18] William J Kovacs. 2016. Metabolism of adrenal steroids. Up To Date. Topic 135 Version 10.0. Prieiga per internetą:
https://www.uptodate.com/contents/metabolism-of-adrenal-steroids?source=see_link. [žiūrėta 2016-01-08]
[19] C. Jung, S. Greco, H. HT Nguyen, J. T Ho, J. G Lewis, D. J Torpy, W. J Inder. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. BMC Endocr Disord. 2014; 14: 91; doi: 10.1186/1472-6823-14-91; [žiūrėta 2016-07-01] [20] W. Winn Chatham. 2016. Glucocorticoid effects on the immune system. Up To Date. Topic 3986 Version 9.0. Prieiga per internetą: https://www.uptodate.co s/glucocorticoid-effects-on-the-immune-system?source=preview&language=en-US&anchor=H6&selectedTitle=1~150#H17m/content; [žiūrėta 2016-10-14]
[21] L. Liu, Y.X. Wang, J. Zhou, F. Long, H.W. Sun,Y. Liu, Y.Z. Chen, C.L. Jiang. Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm. res. 54 (2005) 37–41; DOI 10.1007/s00011-004-1320-y; [žiūrėta 2016-10-18]
37 [22] Gregory Sawicki, Kenan Haver. 2016. Patient education: Asthma treatment in children (Beyond the Basics). Up To Date. Prieiga per internetą: http://www.uptodate.com/contents/asthma-treatment-in-children-beyond-the-basics. Žiūrėta [ 2016-08-02]
[23] W.M.C. van Aalderenand, A.B. Sprikkelman. Inhaled corticosteroids in childhood asthma: the story continues. Eur J Pediatr. 2011 Jun; 170(6): 709–718. doi: 10.1007/s00431-010-1319-z [žiūrėta 2016-08-02]
[24] C. L. Bjornson, D. W. Johnson. Croup in children. CMAJ; 2013 Oct 15; 185(15): 1317–1323. doi: 10.1503/cmaj.121645; žiūrėta [2016-04-13].
[25] National Institute for Health and Care Excellence. Asthma or recurrent wheeze: preventing exacerbations in pre-school children using inhaled corticosteroids. London:NICE; 2017.
[26] Richard H Simon. 2016. Cystic fibrosis: Overview of the treatment of lung disease. Up To Date. Topic 6372 Version 45.0. Prieiga per internetą: https://www.uptodate.com/contents/cystic-fibrosis-
overview-of-the-treatment-of-lung-disease?source=machineLearning&search=glucocorticoids%20cystic%20fybrosis&selectedTitle=2~15 0§ionRank=1&anchor=H14#H14; [žiūrėta 2016-10-15]
[27] L.Ambroggio , M. Test, J.P. Metlay, T.R. Graf, M. A. Blosky, M.Macaluso,S. S. Shah. Adjunct Systemic Corticosteroid Therapy in Children with Community-Acquired Pneumonia in the Outpatient Setting. Journal of Pediatric Infectious Diseases Society. 2014; doi: 10.1093/jpids/piu017 [žiūrėta 2016-10-15]
[28] Arzel-Hézode M, McGoey S, Sternberg D, Vicart S, Eymard B, Fontaine B. Glucocorticoids may trigger attacks in several types of periodic paralysis. Neuromuscul Disord. 2009 Mar;19(3):217-9. doi: 10.1016/j.nmd.2008.12.008 [žiūrėta 2016-08-23]
[29] S. B. Röhr, H. Sauer, S. Gottschling, H. Abdul-Khaliq, L. Gortner, H. Nunold, S. Gräber, S. Meyer. Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit. Swiss Med Wkly. 2014; doi:10.4414/smw.2014.13954; [žiūrėta 2016-08-23]
[30] R. Arkader,Luiz M. Malbouisson, G. Maria Barbaro Del Negro, L. Yamamoto, T. Suely Okay. Factors associated with hyperglycemia and low insulin levels in children undergoing cardiac surgery with cardiopulmonary bypass who received a single high dose of methylprednisolone. Clinics (Sao
Paulo). 2013 Jan; 68(1): 85–92. doi: 10.6061/clinics/2013(01)OA14; [žiūrėta 2016-05-05]
[31] K. A. Wintergerst, M. B. Foster, J. E. Sullivan, Ch. R. Woods. Association of Hyperglycemia, Glucocorticoids, and Insulin Use with Morbidity and Mortality in the Pediatric Intensive Care Unit. Pediatrics Vol. 118 No. 1 July 1, 2006, p. 173 -179. doi: 10.1542/peds.2005-1819; [žiūrėta 2016-05-05]
[32] T. Ulinski, S. Leroy, M. Dubrel, S. Danon, A. Bensman. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone.
38
PediatricNephrology. July 2008, Volume 23,Issue 7, p. 1107-1113. doi: 10.1007/s00467-008-0782-5;
[žiūrėta 2016-10-14]
[33] T. Akamatsu, N. Inui, H. Kusagaya, Y. Nakamura, T. Suda, K. Chida. Evaluation of antibody levels over 3 years after 23-valent pneumococcal polysaccharide vaccination in patients with
pulmonary diseases receiving steroids and immunosuppressive agents. Clinical Biochemistry. Volume 48, Issue 3, February 2015; p. 125–129. doi:10.1016/j.clinbiochem.2014.11.005; [žiūrėta 2016-10-14] [34] M. Goto,N. Shibata, Y. Hasegawa. Efficacy of single serum cortisol reading obtained between 9 AM and 10 AM as an index of adrenal function in children treated with glucocorticoids or synthetic adrenocorticotropic hormone. Clin Pediatr Endocrinol. 2016 Jul; 25(3): 83–89.;
doi: 10.1297/cpe.25.83; [žiūrėta 2016-06-29]
[35] O. Cavkaytar, D. Vuralli, E.A. Yilmaz, B. Buyuktiryaki, O. Soyer, U. M. Sahiner, N. Kandemir, B. E. Sekerel. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use. European Journal of Pediatrics; 2015 Nov;174(11):1421-31. doi: 10.1007/s00431-015-2610-9; [žiūrėta 2016-06-29]
[36] Marianne Sidoroff and Kaija-Leena Kolho. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy. BMC Gastroenterol. 2014; 14: 51; doi: 10.1186/1471-230X-14-51; [žiūrėta 2016-06-29]
[37] E. Hossny, N. Rosario,B. W. Lee,M. Singh, D. El-Ghoneimy,J. Yi SOH, P. Le Souef. The use of inhaled corticosteroids in pediatric asthma: update; World Allergy Organ J. 2016; 9: 26;
doi: 10.1186/s40413-016-0117-0; [žiūrėta 2016-07-01]
[38] Zita Tarjányi. Gergely Montskó, Péter Kenyeres, Zsolt Márton, Roland Hágendorn, Erna Gulyás, Orsolya Nemes, László Bajnok, Gábor L Kovács, Emese Mezősi. Free and total cortisol levels are useful prognostic markers in critically ill patients: a prospective observational study. Eur J Endocrinol;
December 1, 2014171 751-759. Doi:10.1530/EJE-14-0576
[39] Y. Ballestero, J. López-Herce, R. González, M. J. Solana, J. del Castillo, J. Urbano, M. Botran, A. García, N. López, J. M. Bellón. Relationship between hyperglycemia, hormone disturbances, and clinical evolution in severely hyperglycemic post surgery critically ill children: an observational study.
BMC Endocrine Disorders 2014 14:25. doi: 10.1186/1472-6823-14-25; [žiūrėta 2016-07-01]
[40] Andrew Bush. Ikimokyklinio amžiaus vaikų švokštimo sindromo sampratos ir gydymo naujovės. Vaikų pulmonologija ir alergologija. 2016 m. gegužė, Nr. 1 (5978–5986)
[41] Crousos, Aikaterini N Pavlaki, Maria Alexandra Magiakou. Glucocorticoid Therapy and Adrenal Suppression. Endotext. 2011; [žiūrėta 2017-01-29]. Prieiga per internetą:
39 [42] A.Ahmet, V.Brienz2, A.Tran, J.Lemieux, M.Aglipay, N.Barrowman, C.Duffy, J.Roth,
R.Jurencak. Frequency and Duration of Adrenal Suppression Following Glucocorticoid Therapy in Children with Rheumatic Diseases. Arthritis Care & Research. 2016; doi: 10.1002/acr.23123
40
PRIEDAI
Priedas nr.1: Paciento ištyrimo planas
*Intervencinėje grupėje pirmąjį kartą tyrimai imami prieš GKS paskyrimą. **Pastaba: toliau tyrimai imami kas antrą dieną iki hospitalizacijos pabaigos.
Gydymo diena I (Prieš GKS paskyrimą*) II III IV V ** DATA Atliekamas tyrimas T irt i n er eik ia T irt i n er eik ia Bendras kraujo tyrimas + + + + Elektrolitai (natris, kalis) kraujyje + + + + Gliukozė kraujyje + + + + Kortizolis kraujyje + + + + SpO2 Kvėpavimo dažnis Pagalbinių raumenų dalyvavimas kvėpavime Skiriama GKS dozė